Skip to main content

Table 3 Incidence rate of events reported by system organ classification (grouped by MedDRA® coding) in the total cohort (N = 10,925)

From: Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania

MedDRA® System organ classification

Number of events, (n)

Incidence rate per 1,000 (n/N)

Blood and lymphatic system disorders

15

1. 4

Cardiac disorders

5

0. 5

Congenital, familial and genetic disorders

3

0. 3

Ear and labyrinth disorders

2

0. 2

Eye disorders

8

0. 7

Gastrointestinal disorders

150

13. 7

General disorders and administrative site conditions

83

7. 6

Immune system disorders

1

1. 0

Infections and infestations

354

32. 4

Injury, poisoning and procedural complications

5

0. 5

Metabolism and nutrition disorders

14

1. 3

Musculoskeletal and connective tissue disorders

12

1. 1

Nervous system disorders

50

4. 6

Pregnancy, puerperium and perinal conditions

1

0. 1

Psychiatric disorders

4

0. 4

Renal and urinary disorders

2

0. 2

Reproductive system and breast disorders

2

0. 2

Respiratory, thoracic and mediastinal disorders

59

5. 4

Skin and subcutaneous tissue disorders

26

2. 4

Other

1

0. 1